Head and Neck Cancer :: Oral rinse may detect head and neck cancer

A simple oral rinse could detect the early development of head and neck squamous cell carcinoma, according to researchers at the University of Miami?s Sylvester Comprehensive Cancer Center.

Their strategy involves the detection of CD44, a protein biomarker for HNSCC tumors, combined with the detection of cancer-related altered DNA, and could reliably distinguish cancer from benign diseases.

Currently, only 50 percent of head and neck cancer patients are cured of the disease. While late-stage HNSCC has a poor prognosis, cure rates exceed 80 percent if caught early enough.

“Head and neck cancers are devastating for all patients. They are particularly challenging for the poor and disadvantaged, who often do not have the adequate, regular care that makes early detection more likely,” said Elizabeth Franzmann, M.D., assistant professor of otolaryngology at Miami. “Our study has shown that an oral rinse test, simple enough to be administered at any community health center, is likely to detect cancer about 90 percent of the time.”

While CD44 appears on the surface of cells in healthy tissue, it is elevated at least seven- fold times in head and neck cancer. Dr. Franzmann and her colleagues theorized that CD44 could be detected in an oral rinse, which would flush out the CD44 protein by washing over the cellular membranes of interest in the throat and mouth.

According to Dr. Franzmann, their study began with an attempt to find if soluble CD44, alone, was sufficient to distinguish between cancer and other diseases. They collected oral rinses from 102 head and neck cancer patients and 69 control patients with benign diseases and history of tobacco or alcohol use. The test detected two patients with cancer or precancer before the disease was clinically evident. Furthermore, the study detected few false positives among the control group. However, they were only able to detect elevated levels of CD44 in 62 percent of cancer patients.

So, Dr. Franzmann and her colleagues looked for another potential marker of cancer: the hypermethylation of promoter genes. In many cancer cells, DNA can be chemically modified without changing the actual DNA sequence. This hypermethylation process can encourage the growth of cancer by effectively shutting down the genes that control the cell?s growth cycle.

According to Dr. Franzmann, an oral rinse sample contains enough cells to determine the presence of hypermethylated DNA. A pilot study showed that hypermethylation could be found in oral rinse samples from nine out of 11 head and neck cancer patients who had low levels of soluble CD44 from the original study.

“If put into practice, an oral rinse screening test for head and neck squamous cell cancer could be more effective than the PSA test for prostate cancer,” Dr. Franzmann said. “Many lives could be saved through a test that is no more invasive than gargling.”

Do NOT follow this link or you will be banned from the site!